Variability of Delivery of Timolol for the Treatment of Infantile Hemangiomas.

Statistically significant differences were noted in the amount of timolol dispensed according to formulation, brand, and user. Whether this is clinically significant is unknown given the lack of pharmacokinetic data available for timolol.